SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novartis
NVS 126.59+0.9%Nov 6 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Eric Dickson who wrote (22)5/31/1997 12:20:00 PM
From: Sonki   of 296
 
good point. if you send me your fax number, i can fax you my research maerial or if yu want i can entr is earning estimates etc....

i see 23% growth in earning estimate from 97 t 98. now, if the stock is already running ahead. but pe is only 23 or 26. PE is in line w. growth ratio. I am too much in high tech. MRK and PFE are overvalued
to their grown ratio. PFE is owned 26% by insiders. By year 2000+ many mrk patents 11 years will be up. Mrk is priced better then pfe in terms of growh to pe.

Any comments on which one to enter or just sit back and play more high techs.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext